285 related articles for article (PubMed ID: 30470228)
1. Microbial virulence, molecular epidemiology and pathogenic factors of fluoroquinolone-resistant Haemophilus influenzae infections in Guangzhou, China.
Chen D; Wen S; Feng D; Xu R; Liu J; Peters BM; Su D; Lin Y; Yang L; Xu Z; Shirtliff ME
Ann Clin Microbiol Antimicrob; 2018 Nov; 17(1):41. PubMed ID: 30470228
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.
Puig C; Tirado-Vélez JM; Calatayud L; Tubau F; Garmendia J; Ardanuy C; Marti S; de la Campa AG; Liñares J
Antimicrob Agents Chemother; 2015 Jan; 59(1):461-6. PubMed ID: 25385097
[TBL] [Abstract][Full Text] [Related]
3. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions.
Shoji H; Shirakura T; Fukuchi K; Takuma T; Hanaki H; Tanaka K; Niki Y
J Infect Chemother; 2014 Apr; 20(4):250-5. PubMed ID: 24480551
[TBL] [Abstract][Full Text] [Related]
4. Fluoroquinolone resistance in Haemophilus influenzae from nursing home residents in Taiwan: correlation of MICs and mutations in QRDRs.
Chang CM; Shih HI; Wu CJ; Lauderdale TL; Lee NY; Lee CC; Chen YC; Huang CC; Ko WC
J Appl Microbiol; 2020 Jun; 128(6):1624-1633. PubMed ID: 31951091
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activities of new fluoroquinolones against clinical isolates of haemophilus influenzae with ciprofloxacin-resistance-associated alterations in GyrA and ParC.
Yoshizumi S; Takahashi Y; Watanabe Y; Okezaki E; Ishii Y; Tateda K
Chemotherapy; 2004 Dec; 50(6):265-75. PubMed ID: 15608441
[TBL] [Abstract][Full Text] [Related]
6. GyrA and/or ParC alterations of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis.
Kondo H; Ito S; Hatazaki K; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M; Deguchi T
J Infect Chemother; 2018 Mar; 24(3):232-235. PubMed ID: 29138021
[TBL] [Abstract][Full Text] [Related]
7. Rise in Haemophilus influenzae With Reduced Quinolone Susceptibility and Development of a Simple Screening Method.
Seyama S; Wajima T; Yanagisawa Y; Nakaminami H; Ushio M; Fujii T; Noguchi N
Pediatr Infect Dis J; 2017 Mar; 36(3):263-266. PubMed ID: 27870809
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of fluoroquinolones, macrolides, and imipenem resistance in Haemophilus influenzae: analysis of the mutations in QRDRs and assessment of the extent of the AcrAB-TolC-mediated resistance.
Cherkaoui A; Gaïa N; Baud D; Leo S; Fischer A; Ruppe E; François P; Schrenzel J
Eur J Clin Microbiol Infect Dis; 2018 Nov; 37(11):2201-2210. PubMed ID: 30145620
[TBL] [Abstract][Full Text] [Related]
9. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
[TBL] [Abstract][Full Text] [Related]
10. Molecular Characterization of Fluoroquinolone-Resistant Haemophilus parainfluenzae Clinical Isolates in Spain.
López-Hernández I; Machuca J; Díaz de Alba P; Sarvisé C; Gómez F; Rodríguez-Martínez JM; Pascual A
Microb Drug Resist; 2017 Dec; 23(8):935-939. PubMed ID: 28414572
[TBL] [Abstract][Full Text] [Related]
11. Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.
Li X; Mariano N; Rahal JJ; Urban CM; Drlica K
Antimicrob Agents Chemother; 2004 Sep; 48(9):3570-2. PubMed ID: 15328129
[TBL] [Abstract][Full Text] [Related]
12. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
Pérez-Vázquez M; Román F; Aracil B; Cantón R; Campos J
J Clin Microbiol; 2004 Mar; 42(3):1185-91. PubMed ID: 15004073
[TBL] [Abstract][Full Text] [Related]
13.
Honda H; Sato T; Shinagawa M; Fukushima Y; Nakajima C; Suzuki Y; Kuronuma K; Takahashi S; Takahashi H; Yokota SI
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31740553
[No Abstract] [Full Text] [Related]
14. Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species.
Song J; Qiao Y; Kong Y; Ruan Z; Huang J; Song T; Zhang J; Xie X
J Med Microbiol; 2015 Nov; 64(11):1315-1320. PubMed ID: 26243148
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil.
Campioni F; Souza RA; Martins VV; Stehling EG; Bergamini AMM; Falcão JP
Microb Drug Resist; 2017 Jun; 23(4):421-428. PubMed ID: 27559761
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
17. Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV.
Nakase K; Sakuma Y; Nakaminami H; Noguchi N
Anaerobe; 2016 Dec; 42():166-171. PubMed ID: 27793740
[TBL] [Abstract][Full Text] [Related]
18. Presence of plasmid-mediated quinolone resistance determinants and mutations in gyrase and topoisomerase in Salmonella enterica isolates with resistance and reduced susceptibility to ciprofloxacin.
Casas MR; Camargo CH; Soares FB; da Silveira WD; Fernandes SA
Diagn Microbiol Infect Dis; 2016 May; 85(1):85-9. PubMed ID: 26971183
[TBL] [Abstract][Full Text] [Related]
19. Earlier generation quinolones can be useful in identifying Haemophilus influenzae strains with low susceptibility to quinolone isolated from paediatric patients.
Tanaka E; Wajima T; Noguchi N
J Med Microbiol; 2019 Aug; 68(8):1227-1232. PubMed ID: 31215858
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations in gyrA and parC among Shigella sonnei strains from Jiangsu Province of China, 2002-2011.
Gu B; Qin TT; Fan WT; Bi RR; Chen Y; Li Y; Ma P
Int J Infect Dis; 2017 Jun; 59():44-49. PubMed ID: 28392317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
